| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/05/2003 | WO2003046218A1 Methods for detecting cells with numerical chromosomal abnormalities |
| 06/05/2003 | WO2003046217A2 Universal dna chip, method for making same, and uses thereof |
| 06/05/2003 | WO2003046216A1 Nanostructure, in particular for analysing individual molecules |
| 06/05/2003 | WO2003046215A1 Method for detecting hybridization events in nucleic acids |
| 06/05/2003 | WO2003046214A2 Method for analyzing translation-controlled gene expression |
| 06/05/2003 | WO2003046213A2 Method for concentrating and detecting hiv |
| 06/05/2003 | WO2003046211A1 Method for detecting catalytic activity |
| 06/05/2003 | WO2003046209A2 Method and biosensor for detecting macromolecular biopolymers |
| 06/05/2003 | WO2003046208A2 Parallel polymorphism scoring by amplification and error correction |
| 06/05/2003 | WO2003046207A2 Methods for inhibiting deacetylase activity |
| 06/05/2003 | WO2003046206A2 Polymorphism and haplotype scoring by differential amplification of polymorphisms |
| 06/05/2003 | WO2003046203A2 Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers |
| 06/05/2003 | WO2003046201A2 Detection and identification of enteric bacteria |
| 06/05/2003 | WO2003046200A2 Methods for ligand discovery |
| 06/05/2003 | WO2003046180A2 Human cdnas and proteins and uses thereof |
| 06/05/2003 | WO2003046179A2 G-protein coupled receptor lustr2 and uses thereof |
| 06/05/2003 | WO2003046177A1 Extraction of nucleic acid |
| 06/05/2003 | WO2003046154A1 Ϝ-glutamylcysteine-producing yeast and method of screening the same |
| 06/05/2003 | WO2003046149A2 Methods of using improved polymerases |
| 06/05/2003 | WO2003046148A2 Polypeptide quantitation |
| 06/05/2003 | WO2003046146A2 Compositions and methods of selective nucleic acid isolation |
| 06/05/2003 | WO2003046143A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/05/2003 | WO2003046139A2 CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE |
| 06/05/2003 | WO2003046136A2 Single tube screen |
| 06/05/2003 | WO2003046135A2 Osteopontin-related compositions and methods |
| 06/05/2003 | WO2003046133A2 Regulatory nucleic acid assay for diagnostic and library screens |
| 06/05/2003 | WO2003046130A2 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics |
| 06/05/2003 | WO2003046126A2 Artificial genes for use as controls in gene expression analysis systems |
| 06/05/2003 | WO2003046003A2 Plasma protease c1 biopolymer markers predictive of alzheimers disease |
| 06/05/2003 | WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 06/05/2003 | WO2003045989A1 A novel homeobox gene |
| 06/05/2003 | WO2003045988A2 Method to isolate genes involved in aging |
| 06/05/2003 | WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 06/05/2003 | WO2003045983A1 Apolipoprotein biopolymer markers predictive of type ii diabetes |
| 06/05/2003 | WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase |
| 06/05/2003 | WO2003045925A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 06/05/2003 | WO2003045907A2 Sir2 products and activities |
| 06/05/2003 | WO2003045565A1 Apparatus and method for modification of magnetically immobilized biomolecules |
| 06/05/2003 | WO2003045425A1 Muscle transcription factors |
| 06/05/2003 | WO2003045422A1 Agonists and antagonists of prolixin for the treatment of metabolic disorders |
| 06/05/2003 | WO2003045420A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 06/05/2003 | WO2003045318A2 Manipulation of cytokine levels using cd83 gene products |
| 06/05/2003 | WO2003045317A2 Therapeutic protein and treatments |
| 06/05/2003 | WO2003045310A2 Digital assay |
| 06/05/2003 | WO2003045230A2 Novel compositions and methods for cancer |
| 06/05/2003 | WO2003045229A2 Methods and compositions for treating cancer |
| 06/05/2003 | WO2003045227A2 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness |
| 06/05/2003 | WO2003032234A9 Blood and tissue sample assessment of mitochondrial function and biochemistry as a tool for selection for feed efficiency and other production parameters |
| 06/05/2003 | WO2003029418A3 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 06/05/2003 | WO2003027288A9 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3 |
| 06/05/2003 | WO2003025224A8 Differential gene expression in schizophrenia |
| 06/05/2003 | WO2003020952A3 Affinity-shifted probes for quantifying analyte polynucleotides |
| 06/05/2003 | WO2003008929A3 Particle analysis as a detection system for particle-enhanced assays |
| 06/05/2003 | WO2003002764A3 Screening method for identifying cancer therapy-relevant compounds |
| 06/05/2003 | WO2002103371A3 Magnetic-based placement and retention of sensor elements in a sensor array |
| 06/05/2003 | WO2002102306A3 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 06/05/2003 | WO2002099118A3 Method of identifying a polymorphism in cyp2d6 |
| 06/05/2003 | WO2002088750A3 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 06/05/2003 | WO2002088396A9 Reagents and methods for automated in situ or microarray hybridization |
| 06/05/2003 | WO2002083912A3 Production of apomictic seed |
| 06/05/2003 | WO2002083843A3 Outer membrane associated polypeptides |
| 06/05/2003 | WO2002081665A3 Implantation serine proteinases |
| 06/05/2003 | WO2002077261A3 Human potassium channel |
| 06/05/2003 | WO2002074924A3 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 06/05/2003 | WO2002062841A3 Secreted proteins |
| 06/05/2003 | WO2002060932A3 A serpin in bifidobacteria |
| 06/05/2003 | WO2002059307A3 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/05/2003 | WO2002057482A3 Method for differential analysis of bacteria in a sample |
| 06/05/2003 | WO2002048351A3 A method for in vitro molecular evolution of protein function |
| 06/05/2003 | WO2002046230A3 G-protein coupled receptors |
| 06/05/2003 | WO2002042330A3 Cystoskeleton-associated proteins |
| 06/05/2003 | WO2002040673A3 Compositions and methods relating to lung specific genes and proteins |
| 06/05/2003 | WO2002034942A3 Nucleic acid amplification-based methods for the determination of a methylation profile and reagents therefor |
| 06/05/2003 | WO2002031507A3 Non-invasive enzyme screen for tissue remodelling-associated conditions |
| 06/05/2003 | WO2002031179A3 Multiplex assays using nanoparticles |
| 06/05/2003 | WO2002022866A3 Method and sampling kit for analysing material containing nucleic acid |
| 06/05/2003 | WO2002018633A3 Determination of the ability of patients to respond to tumour treatment |
| 06/05/2003 | WO2001092568A3 Method for producing dna-arrays |
| 06/05/2003 | WO2001085989A3 Hypha-specific factors from candida albicans |
| 06/05/2003 | WO2001079546A3 Flavivirus detection and quantification assay |
| 06/05/2003 | WO2001079540A3 Methods for measuring drug resistance |
| 06/05/2003 | WO2001066800A3 Human single nucleotide polymorphisms |
| 06/05/2003 | US20030106107 Genes encoding plant transcription factors |
| 06/05/2003 | US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy |
| 06/05/2003 | US20030106076 Methods for identifying genes expressed in selected lineages, and a novel genes identified using the methods |
| 06/05/2003 | US20030106075 Novel gene encoding organic anion transporter |
| 06/05/2003 | US20030105593 Selection of target segments within target genes using a correspondence regime between different triplets of three bases and the three possible positions of a triplet within a nine-base site; A computer program product |
| 06/05/2003 | US20030105320 Immobilized fluorescent/luminescent probes; detection of amplicons; transcription associated amplification; polymerases |
| 06/05/2003 | US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter |
| 06/05/2003 | US20030105314 Genetic typing of the human cytochrome P450 2A6 gene and related materials and methods |
| 06/05/2003 | US20030105310 Gram negative bacteria for detecting and isolating random amino acid sequences from ricketsia ricketsii; in situ mutagenesis; vaccine delivery; tumor diagnosis and targeting |
| 06/05/2003 | US20030105303 Primate phagocytic leukocyte protein; detection and diagnosis of immunological disorders; cancer detection |
| 06/05/2003 | US20030105293 Human circulating cytokine cc-1 |
| 06/05/2003 | US20030105292 Continously induced g-protein coupled receptors; membrane binding assays |
| 06/05/2003 | US20030105286 Comprises pseudo-isocytosine and pseudo-uracil for increasing binding affinity to DNA/RNA strands |
| 06/05/2003 | US20030105285 Odorant receptors |
| 06/05/2003 | US20030105284 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 06/05/2003 | US20030105082 Genotyping the patient for the presence or absence of a gene encoding apolipoprotein E4 and adapting treatment of the person differentially depending on the presence or absence of gene |
| 06/05/2003 | US20030105059 Regulation of human mast cell protease 6-like enzyme |
| 06/05/2003 | US20030105057 Modulating the rate and/or amount of a cellular process selected from the group consisting of cell growth, cell detachment and cell migration, and cellular apoptosis by altering the RECEPTOR/PTK-STAT pathway of cell |